Rival companies unite for $100m DES thrombosis study
This article was originally published in Clinica
Executive Summary
An international collaboration of eight medtech companies has launched a $100m study to determine how to prevent the formation of life-threatening blood clots in patients treated with drug-eluting stents (DESs).